These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2858619)

  • 1. Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis.
    Stellon AJ; Hegarty JE; Portmann B; Williams R
    Lancet; 1985 Mar; 1(8430):668-70. PubMed ID: 2858619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal.
    Stellon AJ; Keating JJ; Johnson PJ; McFarlane IG; Williams R
    Hepatology; 1988; 8(4):781-4. PubMed ID: 3292363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine for long-term maintenance of remission in autoimmune hepatitis.
    Johnson PJ; McFarlane IG; Williams R
    N Engl J Med; 1995 Oct; 333(15):958-63. PubMed ID: 7666914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis.
    McFarlane IG; Hegarty JE; McSorley CG; McFarlane BM; Williams R
    Lancet; 1984 Oct; 2(8409):954-6. PubMed ID: 6149344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse after azathioprine withdrawal in autoimmune chronic active hepatitis.
    Brunner G; Hopf U
    Lancet; 1985 May; 1(8439):1216. PubMed ID: 2860414
    [No Abstract]   [Full Text] [Related]  

  • 6. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis.
    Hegarty JE; Nouri Aria KT; Portmann B; Eddleston AL; Williams R
    Hepatology; 1983; 3(5):685-9. PubMed ID: 6618435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report.
    Horsmans Y; Piret A; Brenard R; Rahier J; Geubel AP
    J Hepatol; 1994 Aug; 21(2):194-8. PubMed ID: 7989708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of azathioprine in combination with low-dose prednisolone in patients with intractable autoimmune hepatitis type 1.
    Takenami T; Sakaguchi K; Nishimura M; Miyake Y; Miyashita M; Terao M; Fujiwara A; Tsuji T
    Acta Med Okayama; 2001 Dec; 55(6):341-7. PubMed ID: 11779096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: favorable response to prednisone and azathioprine.
    Bellary S; Schiano T; Hartman G; Black M
    Ann Intern Med; 1995 Jul; 123(1):32-4. PubMed ID: 7762911
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiopathic chronic active hepatitis: a diagnostic and therapeutic dilemma.
    Al-Fadda M; Zafar M; Ayub A; al-Kahtani K
    J Clin Gastroenterol; 1994 Dec; 19(4):313-7. PubMed ID: 7876513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ; Hay JE; Rakela J
    Mayo Clin Proc; 1990 Jan; 65(1):23-30. PubMed ID: 2296210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid therapy in chronic active hepatitis.
    Bateson MC
    Postgrad Med J; 1990 Sep; 66(779):781-3. PubMed ID: 2235818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic active hepatitis in the elderly.
    Selby CD; Toghill PJ
    Age Ageing; 1986 Nov; 15(6):350-6. PubMed ID: 3799364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of autoimmune hepatitis.
    Johnson PJ
    Gut; 1997 Jul; 41(1):3-4. PubMed ID: 9274462
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral pulse prednisone therapy after relapse of severe autoimmune chronic active hepatitis. A prospective randomized treatment trial evaluating clinical, biochemical, and lymphocyte subset responses.
    Czaja AJ; Wang KK; Shiels MT; Katzmann JA
    J Hepatol; 1993 Feb; 17(2):180-6. PubMed ID: 8445231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of HBsAg-positive chronic active hepatitis with corticosteroids and/or azathioprine. A prospective study.
    Manzillo G; Piccinino F; Sagnelli E; Izzo CM; Pasquale G; Maio G; Filippini P; Felaco FM
    Ric Clin Lab; 1983; 13(2):261-8. PubMed ID: 6622929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic active hepatitis and other liver diseases with corticosteroid agents.
    Mackay IR
    Med J Aust; 1987 Apr; 146(7):370-4. PubMed ID: 3561294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine versus prednisone in chronic active hepatitis and non-alcoholic cirrhosis. Effect on survival and activity.
    Scand J Gastroenterol; 1982 Sep; 17(6):817-24. PubMed ID: 6760378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of corticosteroid-azathioprine resistant autoimmune hepatitis with cyclosporin A.
    Senturk H
    Indian J Gastroenterol; 1995 Jul; 14(3):110-1. PubMed ID: 7657365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic active hepatitis. An analysis of three controlled trials.
    Wright EC; Seeff LB; Berk PD; Jones A; Plotz PH
    Gastroenterology; 1977 Dec; 73(6):1422-30. PubMed ID: 334625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.